Global MarketsSeptember 23 at 04:29 AM

GSK (GSK LN) says they target mid-term sales of above USD 40bln (exp. USD 36.4bln), with the gap attributed entirely to oncology; sees USD 1.9bln of organisational savings

StockNow breaking-news AI analysis

GSK targets mid-term sales above USD 40 billion, surpassing USD 36.4 billion expectations driven entirely by oncology, alongside USD 1.9 billion in organizational savings.

1 stocks

GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)$50.24Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

Iranian Foreign Ministry spokesperson Baghaei says engagement with the US took place through a Qatari mediator to convey Iran’s conditions, Nournews reports

Geopolitics

Diplomatic sources suggest that "Yesterday's talks between the US and Iran did not achieve the minimum required to resume negotiations", Hayom reports

Geopolitics

GSK (GSK LN) says they target mid-term sales of above USD 40bln (exp. USD 36.4bln), with the gap attributed entirely to oncology; sees USD 1.9bln of organisational savings

Related stocks

What do investors think?

Today's market highlights

Iranian Foreign Ministry spokesperson Baghaei says engagement with the US took place through a Qatari mediator to convey Iran’s conditions, Nournews reports

Diplomatic sources suggest that "Yesterday's talks between the US and Iran did not achieve the minimum required to resume negotiations", Hayom reports

Unconfirmed reports of explosions in the Strait of Hormuz; some suggestion that four missiles have been launched towards Hormuz - UNVERIFIED